<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BR</journal-id>
<journal-title-group>
<journal-title>Biomedical Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">2049-9434</issn>
<issn pub-type="epub">2049-9442</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/br.2018.1150</article-id>
<article-id pub-id-type="publisher-id">BR-0-0-1150</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Increased intestinal ethanol following consumption of fructooligosaccharides in rats</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Yamaguchi</surname><given-names>Masahiro</given-names></name>
<xref rid="af1-br-0-0-1150" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Yang</surname><given-names>Yongshou</given-names></name>
<xref rid="af1-br-0-0-1150" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Ando</surname><given-names>Misaki</given-names></name>
<xref rid="af1-br-0-0-1150" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Kumrungsee</surname><given-names>Thanutchaporn</given-names></name>
<xref rid="af1-br-0-0-1150" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Kato</surname><given-names>Norihisa</given-names></name>
<xref rid="af1-br-0-0-1150" ref-type="aff">1</xref>
<xref rid="c1-br-0-0-1150" ref-type="corresp"/></contrib>
<contrib contrib-type="author"><name><surname>Okazaki</surname><given-names>Yukako</given-names></name>
<xref rid="af2-br-0-0-1150" ref-type="aff">2</xref></contrib>
</contrib-group>
<aff id="af1-br-0-0-1150"><label>1</label>Department of Biofunctional Science and Technology, Graduate School of Biosphere Science, Hiroshima University, Higashi-Hiroshima, Hiroshima 739-8528, Japan</aff>
<aff id="af2-br-0-0-1150"><label>2</label>Faculty of Human Life Sciences, Fuji Women&#x0027;s University, Ishikari, Hokkaido 061-3204, Japan</aff>
<author-notes>
<corresp id="c1-br-0-0-1150"><italic>Correspondence to</italic>: Professor Norihisa Kato, Department of Biofunctional Science and Technology, Graduate School of Biosphere Science, Hiroshima University, 1-4-4 Kagamiyama, Higashi-Hiroshima, Hiroshima 739-8528, Japan, E-mail: <email>nkato@hiroshima-u.ac.jp</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>11</month>
<year>2018</year></pub-date>
<pub-date pub-type="epub">
<day>14</day>
<month>09</month>
<year>2018</year></pub-date>
<volume>9</volume>
<issue>5</issue>
<fpage>427</fpage>
<lpage>432</lpage>
<history>
<date date-type="received"><day>04</day><month>01</month><year>2018</year></date>
<date date-type="accepted"><day>10</day><month>09</month><year>2018</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2018, Spandidos Publications</copyright-statement>
<copyright-year>2018</copyright-year>
</permissions>
<abstract>
<p>Previous studies have suggested that ethanol is a fermentation product of microflora. However, it is unknown whether this ethanol production is elevated by intake of prebiotics. Prebiotics are considered to enhance the production of short-chain fatty acids (SCFAs) as a fermentation product of beneficial bacteria. In the present study, the effect of fructooligosaccharides (FOS) consumption on intestinal ethanol levels was investigated. Rats were fed a diet with or without 10&#x0025; FOS for two weeks. Consequently, FOS intake significantly increased ethanol levels per gram of ileum and cecum digesta of the rats (3.5-fold and 1.9-fold, respectively, P&#x003C;0.01). The numbers of cecum <italic>Bifidobacterium</italic> (producer of ethanol and lactate) were significantly increased by FOS intake (P&#x003C;0.05) and correlated with the cecum ethanol levels per gram of cecum (r=0.626, P&#x003C;0.05). FOS intake also led to a significant increase in the cecum levels of SCFAs, namely lactate, propionate and n-butyrate (P&#x003C;0.05). Furthermore, ethanol levels were significantly correlated with lactate levels (r=0.691, P&#x003C;0.01), but not with propionate or n-butyrate levels (r=0.449 and 0.493, respectively, P&#x003E;0.05). The current study, to the best of our knowledge, is the first to indicate that FOS intake significantly increases the level of intestinal ethanol. Therefore, dietary FOS may affect the intestinal health status of animals by elevating their ethanol levels, without direct ethanol consumption.</p>
</abstract>
<kwd-group>
<kwd>fructooligosaccharides</kwd>
<kwd>prebiotics</kwd>
<kwd>ethanol</kwd>
<kwd><italic>Bifidobacterium</italic></kwd>
<kwd>intestine</kwd>
<kwd>short-chain fatty acids</kwd>
<kwd>rat</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Previous studies have suggested that ethanol is a fermentation product of intestinal microflora (<xref rid="b1-br-0-0-1150" ref-type="bibr">1</xref>&#x2013;<xref rid="b3-br-0-0-1150" ref-type="bibr">3</xref>). Additionally, it has been reported that ethanol is produced from glucose or fructooligosaccharides (FOS) by several intestinal bacteria, including <italic>Bifidobacterium, Lactobacillus fermentum</italic> and <italic>Weissella confusa</italic> (<xref rid="b4-br-0-0-1150" ref-type="bibr">4</xref>). However, the extent to which these bacteria are responsible for ethanol production is unknown. Furthermore, there is a lack of studies on the effects of dietary factors, such as prebiotics, on intestinal ethanol production in animals without ethanol consumption. Consumption of prebiotics including FOS and inulin has been reported to enhance the intestinal fermentation process by elevating levels of probiotics including <italic>Bifidobacterium</italic> and <italic>Lactobacillus</italic> (<xref rid="b5-br-0-0-1150" ref-type="bibr">5</xref>). It has been reported that addition of FOS to culture medium stimulates <italic>in vitro</italic> growth of <italic>Bifidobacterium</italic> (<xref rid="b6-br-0-0-1150" ref-type="bibr">6</xref>,<xref rid="b7-br-0-0-1150" ref-type="bibr">7</xref>). Dietary FOS is resistant to digestion and is metabolised by the microflora in the large intestine into short-chain fatty acids (SCFAs). Increasing data suggest that prebiotics may prevent several chronic diseases, including colon cancer, inflammatory bowel disease, alcoholic steatohepatitis and diabetes, by elevating probiotic and SCFA levels (<xref rid="b8-br-0-0-1150" ref-type="bibr">8</xref>,<xref rid="b9-br-0-0-1150" ref-type="bibr">9</xref>).</p>
<p>A high intake of ethanol is harmful due to increased risk of several diseases including coronary heart disease, brain diseases and colon cancer (<xref rid="b10-br-0-0-1150" ref-type="bibr">10</xref>). Conversely, it has been suggested that low ethanol intake is associated with lower risk of such diseases (<xref rid="b10-br-0-0-1150" ref-type="bibr">10</xref>,<xref rid="b11-br-0-0-1150" ref-type="bibr">11</xref>). Therefore, it is of interest to elucidate the modulation of intestinal ethanol production by dietary factors. Considering the previous findings, the present study hypothesised that FOS intake may elevate ethanol production by the intestinal microflora. Indeed, the beneficial effects of dietary prebiotics on obese phenotype, impaired gut permeability, cardiac function and hyperlipidemia are particularly prominent in animals on a high-fat (HF) diet (<xref rid="b12-br-0-0-1150" ref-type="bibr">12</xref>,<xref rid="b13-br-0-0-1150" ref-type="bibr">13</xref>). Therefore, in the current study, the effect of FOS intake on intestinal ethanol levels in rats fed on a HF diet was investigated.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Animals and diets</title>
<p>A total of 16 male, specific pathogen-free Sprague-Dawley rats (3 weeks old) were purchased from Hiroshima Laboratory Animal Centre (Hiroshima, Japan) and maintained according to the Guide for the Care and Use of Laboratory Animals of Hiroshima University (Hiroshima, Japan). The study was approved by the Research Ethics Committee of Hiroshima University (approval no.: C15-12). The rats were individually housed in an air-conditioned room at 23&#x2013;24&#x00B0;C under a 12-h light/dark cycle (lights on from 08:00 a.m. to 8:00 p.m. Following acclimatization with a non-purified commercial rodent diet (MF diet for rat and mouse; Oriental Yeast Co., Ltd., Tokyo, Japan) for 3 days, the rats (mean body weight, 68.3&#x00B1;0.5 g) were randomly assigned to one of two groups (n=8 rats per group) based on experimental diet. The compositions of the experimental HF diets with and without FOS supplementation are summarised in <xref rid="tI-br-0-0-1150" ref-type="table">Table I</xref>. In these diets, the 30&#x0025; beef tallow and 10&#x0025; FOS were in accordance with previous studies (<xref rid="b14-br-0-0-1150" ref-type="bibr">14</xref>,<xref rid="b15-br-0-0-1150" ref-type="bibr">15</xref>). The rats were randomly assigned to one of the two diets supplemented with or without 10&#x0025; FOS (w/w; Wako Pure Chemical Industries, Ltd., Osaka, Japan). Equal quantities of the experimental diets were incorporated daily into food cups at 17:00 (9, 10, 12, 14 and 15 g on days 1, 2&#x2013;4, 5&#x2013;7, 8&#x2013;12 and 13&#x2013;14, respectively) to prevent differences in food intake. Food intake was determined from the food consumed each day until the next day&#x0027;s food was served. The weight of spilled food was recorded daily and appropriately incorporated into calculations of food intake. At the end of the feeding period, the rats were sacrificed by decapitation following brief exposure to 3&#x2013;4&#x0025; isoflurane gas (Wako Pure Chemical Industries, Ltd., Osaka, Japan) mixed with air in an anesthesia chamber. A total of 8 ml blood was collected from the neck, and serum was separated by centrifugation at 2,000 &#x00D7; g for 20 min at 4&#x00B0;C and stored at &#x2212;80&#x00B0;C. The intestinal digesta was immediately isolated, weighed and stored at &#x2212;80&#x00B0;C until the subsequent analyses of ethanol, organic acid and beneficial bacteria.</p>
</sec>
<sec>
<title>Cecum and serum ethanol</title>
<p>To determine ethanol levels by gas chromatography, 100 mg of the intestinal digesta and 100 &#x00B5;l serum were transferred into individual ice-cold 0.6 N perchloric acid solutions (PCA). The cecum PCA solution was homogenized on ice (Polytron RT-MR2100; Kinematica AG, Littau-Luzern, Switzerland), and the serum PCA solution was mixed for 10 sec on a vortex-mixer (<xref rid="b17-br-0-0-1150" ref-type="bibr">17</xref>). The extracted samples were centrifuged at 10,000 &#x00D7; g at 4&#x00B0;C for 5 min, and the supernatant was stored as 1.0 ml samples collected in 20 ml glass vials at &#x2212;80&#x00B0;C until measurement. 1-Propanol at a final concentration of 100 ppm was included as internal standard prior to analysis. A gas-chromatograph (GC-2014; Shimadzu Corporation, Kyoto, Japan) equipped with a flame ionization detector was used for analysis. A headspace autosampler (HT2000H; ALPHA M.O.S. Japan K.K., Tokyo, Japan) was used to load the analyses. DB-WAX capillary columns (1.0 &#x00B5;m thickness, 30 m length, 0.53 mm internal diameter) from Agilent Technologies Japan, Ltd. (Tokyo, Japan) were applied. Samples were incubated for 30 min at 65&#x00B0;C in the head-space autosampler. Samples (0.5 ml) were injected into the column at a rate of 1 ml/min with the injector maintained at 200&#x00B0;C and detector at 250&#x00B0;C. An initial temperature of 40&#x00B0;C was maintained for 1 min and then the column oven temperature was increased from 40 to 80&#x00B0;C at a rate of 8&#x00B0;C/min and then maintained at 80&#x00B0;C for 1 min. The column oven temperature was increased from 20 to 180&#x00B0;C at a rate of 20&#x00B0;C/min and then maintained at 180&#x00B0;C for 4 min. The flow rate of the carrier gas (N<sub>2</sub>) was 1.0 ml/min (split ratio 10:1). Standard curves were linear across four different concentrations (0.00, 3.25, 6.50 and 13.00 mmol/l) of ethanol (R<sup>2</sup>&#x003E;0.99), and used for the assay of ethanol levels in the samples.</p>
</sec>
<sec>
<title>Cecum microflora</title>
<p>For the analysis of intestinal microflora, bacterial genomic DNA was isolated from the cecum digesta using an UltraClean&#x2122; Fecal DNA extraction kit (MO BIO Laboratories; Qiagen, Inc., Valencia, CA, USA) according to the manufacturer&#x0027;s instructions. The purified DNA was eluted in 100 &#x00B5;l elution buffer (5 mM Tris-HCl, pH 8.5), and the quality and quantity of DNA were determined by measuring the absorbance at 260 and 280 nm using a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies; Thermo Fisher Scientific, Inc., Wilmington, DE, USA). Samples were stored at &#x2212;20&#x00B0;C. Real-time quantitative polymerase chain reaction (qPCR) was performed to investigate the variation in the total number of bacteria, including of <italic>Bifidobacterium</italic> spp. and <italic>Lactobacillus</italic> spp. The 16S rRNA primers for <italic>Bifidobacterium</italic> spp. and <italic>Lactobacillus</italic> spp. used for qPCR have been described previously (<xref rid="b14-br-0-0-1150" ref-type="bibr">14</xref>). The total volume of reagent mixture for each PCR was 20 &#x00B5;l [4.4 &#x00B5;l distilled water, 10 &#x00B5;l Master mix (Takara Bio, Inc., Otsu, Japan), 2 &#x00B5;l Plus solution (Takara Bio, Inc., Otsu, Japan), 0.8 &#x00B5;l of each forward and reverse primer and 2 &#x00B5;l DNA]. The reaction conditions were as follows: 95&#x00B0;C for 30 sec, followed by 40 cycles at 95&#x00B0;C for 5 sec, 55&#x00B0;C for 15 sec and 72&#x00B0;C for 30 sec. The fluorescent products were detected at the last step of each cycle. Melting curve analysis was performed following amplification to distinguish the targeted PCR product from the non-targeted PCR products. Data were analysed using the second derivative maximum method of the StepOneTM Real-time PCR software version 2.3 (Applied Biosystems; Thermo Fisher Scientific, Inc.). The copy numbers of <italic>Bifidobacterium</italic> spp. and <italic>Lactobacillus</italic> spp./&#x00B5;l were determined for the standard plasmid solution of these bacteria [(cut standard plasmid mixture ng/&#x00B5;l) &#x00D7; (molecules bp/1.0 &#x00D7; 10<sup>9</sup> ng) &#x00D7; (1/660 DNA length bp/plasmid)=plasmid copies/&#x00B5;l] (<xref rid="b14-br-0-0-1150" ref-type="bibr">14</xref>). Real-time qPCR products were run as five 10-fold serial dilutions of each standard mixture to compare the threshold cycle number with the copy number of the target sequence and to generate standard curves for the quantification of unknown samples. Typically, standard curves were linear across five orders of magnitude (R<sup>2</sup>&#x003E;0.98).</p>
</sec>
<sec>
<title>Cecum SCFAs</title>
<p>Cecum SCFAs were measured according to an internal standard method using high-performance liquid chromatography (HPLC; L-2130; Hitachi, Ltd., Tokyo, Japan) equipped with an Aminex HPX-87H ion exclusion column (7.8 mm internal diameter &#x00D7; 30 cm; Bio-Rad, Laboratories, Hercules, CA, USA) (<xref rid="b18-br-0-0-1150" ref-type="bibr">18</xref>). Briefly, 500 mg cecum digesta was homogenised in 5 ml 50 mmol/l H<sub>2</sub>SO<sub>4</sub> containing 10 mmol/l 2,2-dimethyl butyric acid as an internal standard and subsequently centrifuged at 17,000 &#x00D7; g at 2&#x00B0;C for 20 min. The supernatant was ultrafiltered, and the filtrate was applied to the HPLC column.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>Data are expressed as the mean &#x00B1; standard error of the mean. Data were analyzed by Student&#x0027;s t-test after statistical outliers were removed using the Smirnov-Grubbs rejection test. In addition, association of cecum ethanol levels with cecum <italic>Bifidobacterium</italic> and SCFA levels was assessed using Spearman rank correlation analysis. The data analysis was performed using Excel Statistics 2010 for Windows (Microsoft Corporation, Redmond, WA, USA). For all tests, P&#x003C;0.05 was considered to indicate statistical significance.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Food intake and body weight</title>
<p>Dietary manipulation had no significant effect on total food intake over 14 days or on final body weight (P&#x003E;0.05; <xref rid="tII-br-0-0-1150" ref-type="table">Table II</xref>).</p>
</sec>
<sec>
<title>Intestinal and serum ethanol levels</title>
<p>The weights of the ileum digesta were unaffected by FOS intake (control vs. FOS: 0.30&#x00B1;0.02 vs. 0.26&#x00B1;0.05 g; P&#x003E;0.05). Ethanol levels per gram of ileum digesta were significantly increased 3.5-fold by FOS intake (P&#x003C;0.01; <xref rid="f1-br-0-0-1150" ref-type="fig">Fig. 1A</xref>). In the total ileum digesta, FOS intake significantly increased ethanol levels by 3.6-fold (P&#x003C;0.01; <xref rid="f1-br-0-0-1150" ref-type="fig">Fig. 1B</xref>). The weights of the cecum digesta were markedly increased 4.2-fold by FOS intake (control vs. FOS: 1.33&#x00B1;0.06 vs. 5.54&#x00B1;0.48 g; P&#x003C;0.01). The ethanol levels per gram of cecum digesta were significantly increased 1.9-fold by FOS intake (P&#x003C;0.01; <xref rid="f1-br-0-0-1150" ref-type="fig">Fig. 1C</xref>). In the total cecum digesta, ethanol levels were markedly increased by FOS intake by 7.9-fold (P&#x003C;0.01; <xref rid="f1-br-0-0-1150" ref-type="fig">Fig. 1D</xref>). Serum ethanol levels were marginally but significantly increased by FOS intake (control vs. FOS: 2.63&#x00B1;0.05 vs. 2.84&#x00B1;0.07 mM; P&#x003C;0.05).</p>
</sec>
<sec>
<title>Cecum bacteria and SCFAs</title>
<p>Compared with the control group, the copy numbers of <italic>Bifidobacterium</italic> per gram of cecum digesta were markedly increased 4.2-fold in the FOS group (P&#x003C;0.05; <xref rid="tII-br-0-0-1150" ref-type="table">Table II</xref>). However, the numbers of <italic>Lactobacillus</italic> per gram of cecum digesta were unaffected (P&#x003E;0.05). The numbers of <italic>Bifidobacterium</italic> were positively correlated with ethanol level per gram of cecum digesta (r=0.626, P=0.017; <xref rid="f2-br-0-0-1150" ref-type="fig">Fig. 2</xref>).</p>
<p>Succinate and acetate levels per gram of cecum digesta were decreased by FOS intake (2.5- and 2.7-fold decrease, respectively; P&#x003C;0.05; <xref rid="tII-br-0-0-1150" ref-type="table">Table II</xref>). By contrast, FOS intake significantly increased lactate, propionate and n-butyrate levels per gram of cecum digesta (2.4-, 1.7- and 1.4-fold, respectively; P&#x003C;0.05; <xref rid="tII-br-0-0-1150" ref-type="table">Table II</xref>). In the total cecum digesta, the levels of lactate, propionate, n-butyrate and total SCFAs were markedly increased by the FOS diet (10.3-, 7.3-, 6.0- and 4.0-fold, respectively, P&#x003C;0.01). The ethanol levels per gram of cecum digesta were negatively correlated with acetate levels (r=&#x2212;0.558, P=0.025; <xref rid="f3-br-0-0-1150" ref-type="fig">Fig. 3A</xref>) and positively correlated with lactate levels (r=0.691, P=0.006; <xref rid="f3-br-0-0-1150" ref-type="fig">Fig. 3B</xref>). However, ethanol levels were not significantly correlated with the level of propionate (r=0.449, P=0.081; <xref rid="f3-br-0-0-1150" ref-type="fig">Fig. 3C</xref>) or butyrate (r=0.493, P=0.052; <xref rid="f3-br-0-0-1150" ref-type="fig">Fig. 3D</xref>).</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>The present study demonstrated, to the best of our knowledge for the first time, that FOS intake significantly increased ethanol levels in the intestinal digesta of rats without direct consumption of ethanol. The results further indicated that the cecum levels of ethanol were associated with <italic>Bifidobacterium</italic> numbers. Previous <italic>in vitro</italic> studies have indicated that ethanol is produced by <italic>Bifidobacterium</italic> from glucose or FOS (<xref rid="b2-br-0-0-1150" ref-type="bibr">2</xref>,<xref rid="b3-br-0-0-1150" ref-type="bibr">3</xref>). Other <italic>in vitro</italic> studies have suggested that the addition of FOS stimulates the growth of <italic>Bifidobacterium</italic> (<xref rid="b6-br-0-0-1150" ref-type="bibr">6</xref>,<xref rid="b7-br-0-0-1150" ref-type="bibr">7</xref>). Therefore, the increase in intestinal ethanol levels may, at least in part, be mediated by an increased abundance of <italic>Bifidobacterium</italic> bacteria in the intestines of rats fed FOS. However, a previous study suggested ethanol is degraded to acetate by intestinal bacteria such as <italic>Bifidobacterium</italic> and <italic>Lactobacillus</italic> (<xref rid="b19-br-0-0-1150" ref-type="bibr">19</xref>). Taken together, it may be hypothesized that <italic>Bididobacterium</italic> serves a role in the degradation of ethanol in rats following consumption of ethanol, while <italic>Bifidobacterium</italic> may stimulate the production of ethanol in rats lacking consumption of ethanol. Since the abundance of cecum <italic>Lactobacillus</italic> was unaffected by FOS in the current study, the possibility of the involvement of <italic>Lactobacillus</italic> in the mechanisms underlying the increase in intestinal ethanol was negated. At present, the possibilities of higher production and/or lower degradation of ethanol by other intestinal bacteria in rats fed FOS remains to be examined. A recent metagenome study demonstrated that FOS intake increased or decreased the abundance of a variety of bacteria in addition to <italic>Bifidobacterium</italic> in rats (<xref rid="b20-br-0-0-1150" ref-type="bibr">20</xref>). Accordingly, further <italic>in vitro</italic> study is necessary to investigate if each of the intestinal bacteria present can produce or degrade ethanol.</p>
<p><italic>Bifidobacterium</italic> is established to be a producer of lactate and ethanol (<xref rid="b2-br-0-0-1150" ref-type="bibr">2</xref>,<xref rid="b3-br-0-0-1150" ref-type="bibr">3</xref>). The current study also identified a significant positive correlation between the cecum levels of ethanol and lactate. It has been suggested that lactate is produced from pyruvate and that ethanol is produced from acetyl-CoA, a metabolite of pyruvate, in <italic>Bifidobacterium</italic> (<xref rid="b2-br-0-0-1150" ref-type="bibr">2</xref>,<xref rid="b3-br-0-0-1150" ref-type="bibr">3</xref>). Therefore, higher production of lactate may be associated with a higher production of ethanol. Further studies should be conducted to elucidate the underlying mechanisms of higher production of ethanol following elevated FOS intake.</p>
<p>High ethanol intake is well established to cause toxic effects and increase the risk of several diseases, including liver disease, coronary heart diseases and cancer (<xref rid="b21-br-0-0-1150" ref-type="bibr">21</xref>). However, previous studies have suggested that low or moderate ethanol intake is associated with a lower risk of developing diseases including coronary heart disease, brain diseases and cancers (<xref rid="b10-br-0-0-1150" ref-type="bibr">10</xref>,<xref rid="b11-br-0-0-1150" ref-type="bibr">11</xref>). Previous experimental studies by our group have also suggested beneficial effects of a low ethanol dose on liver function and aging in rodents (<xref rid="b22-br-0-0-1150" ref-type="bibr">22</xref>,<xref rid="b23-br-0-0-1150" ref-type="bibr">23</xref>). Therefore, further studies are necessary to investigate whether increased ethanol levels in rats fed FOS are equivalent to the toxic or beneficial levels reported in animals, and to determine the overall ethanol production rate by intestinal microflora in rats fed FOS. In this regard, a study by Zhong <italic>et al</italic> (<xref rid="b24-br-0-0-1150" ref-type="bibr">24</xref>) reported that rats administered a Lieber-DeCarli liquid diet mixed with 5&#x0025; (w/v) ethanol for 8 weeks exhibited an elevation in cecum ethanol levels from 2&#x2013;3 to 20&#x2013;30 &#x00B5;mol/g digesta. The increased intestinal ethanol levels were associated with fatty liver disease pathology and reduced intestinal barrier function (<xref rid="b24-br-0-0-1150" ref-type="bibr">24</xref>). Their results imply that increased levels of cecum ethanol (&#x003E;20 &#x00B5;mol per gram of digesta) in rats fed ethanol may be harmful for the host. A more recent study using Caco-2 cells monolayers as an <italic>in vitro</italic> tight junction model indicated that the addition of 6&#x0025; (v/v, 1 mmol/ml) ethanol to the culture medium decreased intestinal cell barrier function, although cell viability and lactate dehydrogenase release (cytotoxicity) were unaffected (<xref rid="b25-br-0-0-1150" ref-type="bibr">25</xref>). The current study identified the production of 4&#x2013;5 &#x00B5;mol ethanol per gram of cecum digesta in rats fed FOS. Thus, the levels of ethanol in FOS-fed rats appear to be lower than the harmful levels of ethanol reported (<xref rid="b24-br-0-0-1150" ref-type="bibr">24</xref>,<xref rid="b25-br-0-0-1150" ref-type="bibr">25</xref>). Further study is necessary to investigate whether the increased ethanol levels in the cecum of rats fed FOS are close to the beneficial levels in those administered low-dose ethanol in our previous studies (<xref rid="b22-br-0-0-1150" ref-type="bibr">22</xref>,<xref rid="b23-br-0-0-1150" ref-type="bibr">23</xref>).</p>
<p>In conclusion, the current study demonstrated that dietary FOS increased ethanol levels in the intestinal digesta of rats fed a HF diet. The results imply that FOS intake has an impact on intestinal health by increasing ethanol levels. The findings also indicate the importance of dietary prebiotics as an environmental factor in alcohol-use disorders and may provide novel insight into the link between prebiotics and diseases related to alcohol consumption.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>This study was presented as part of an abstract at the 17th Global Dieticians and Nutritionists Annual Meeting October 3 2017 in Kuala Lumpur, Malaysia and published under Masahiro Yamaguchi <italic>et al</italic> in J Nutr Food Sci 7: 6, 2017.</p>
</ack>
<sec>
<title>Funding</title>
<p>The current study was financially supported by the HIRAKU consortium, Hiroshima University.</p>
</sec>
<sec>
<title>Availability of data and materials</title>
<p>The analyzed data sets generated during the study are available from the correspondence author on reasonable request.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>MY, YY and NK contributed to the study design, MY, YY, MA and YO acquired the data. MY and TK analyzed and interpreted the data. MY and NK wrote the manuscript and approved the contents of the manuscript. The final version of the manuscript has been read and approved by all authors.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>The study protocol was approved by the institutional ethics committee of Hiroshima University (approval no: C15-12).</p>
</sec>
<sec>
<title>Consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<glossary>
<def-list>
<title>Abbreviations</title>
<def-item><term>FOS</term><def><p>fructooligosaccharides</p></def></def-item>
<def-item><term>SCFAs</term><def><p>short-chain fatty acids</p></def></def-item>
<def-item><term>HF</term><def><p>high-fat</p></def></def-item>
<def-item><term>qPCR</term><def><p>quantitative polymerase chain reaction</p></def></def-item>
<def-item><term>HPLC</term><def><p>high-performance liquid chromatography</p></def></def-item>
</def-list>
</glossary>
<ref-list>
<title>References</title>
<ref id="b1-br-0-0-1150"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cope</surname><given-names>K</given-names></name><name><surname>Risby</surname><given-names>T</given-names></name><name><surname>Diehl</surname><given-names>AM</given-names></name></person-group><article-title>Increased gastrointestinal ethanol production in obese mice: Implications for fatty liver disease pathogenesis</article-title><source>Gastroenterology</source><volume>119</volume><fpage>1340</fpage><lpage>1347</lpage><year>2000</year><pub-id pub-id-type="doi">10.1053/gast.2000.19267</pub-id><pub-id pub-id-type="pmid">11054393</pub-id></element-citation></ref>
<ref id="b2-br-0-0-1150"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Meulen</surname><given-names>R</given-names></name><name><surname>Adriany</surname><given-names>T</given-names></name><name><surname>Verbrugghe</surname><given-names>K</given-names></name><name><surname>De Vuyst</surname><given-names>L</given-names></name></person-group><article-title>Kinetic analysis of bifidobacterial metabolism reveals a minor role for succinic acid in the regeneration of NAD&#x002B; through its growth-associated production</article-title><source>Appl Environ Microbiol</source><volume>72</volume><fpage>5204</fpage><lpage>5210</lpage><year>2006</year><pub-id pub-id-type="doi">10.1128/AEM.00146-06</pub-id><pub-id pub-id-type="pmid">16885266</pub-id></element-citation></ref>
<ref id="b3-br-0-0-1150"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivi&#x00E8;re</surname><given-names>A</given-names></name><name><surname>Selak</surname><given-names>M</given-names></name><name><surname>Lantin</surname><given-names>D</given-names></name><name><surname>Leroy</surname><given-names>F</given-names></name><name><surname>De Vuyst</surname><given-names>L</given-names></name></person-group><article-title>Bifidobacteria and butyrate producing colon bacteria: Importance and strategies for their stimulation in the human gut</article-title><source>Front Microbiol</source><volume>7</volume><fpage>979</fpage><lpage>990</lpage><year>2016</year><pub-id pub-id-type="doi">10.3389/fmicb.2016.00979</pub-id><pub-id pub-id-type="pmid">27446020</pub-id></element-citation></ref>
<ref id="b4-br-0-0-1150"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elshaghabee</surname><given-names>FM</given-names></name><name><surname>Bockelmann</surname><given-names>W</given-names></name><name><surname>Meske</surname><given-names>D</given-names></name><name><surname>de Vrese</surname><given-names>M</given-names></name><name><surname>Walte</surname><given-names>HG</given-names></name><name><surname>Schrezenmeir</surname><given-names>J</given-names></name><name><surname>Heller</surname><given-names>KJ</given-names></name></person-group><article-title>Ethanol production by selected intestinal microorganisms and lactic acid bacteria growing under different nutritional conditions</article-title><source>Front Microbiol</source><volume>7</volume><fpage>47</fpage><lpage>59</lpage><year>2016</year><pub-id pub-id-type="doi">10.3389/fmicb.2016.00047</pub-id><pub-id pub-id-type="pmid">26858714</pub-id></element-citation></ref>
<ref id="b5-br-0-0-1150"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barona</surname><given-names>M</given-names></name><name><surname>Roy</surname><given-names>D</given-names></name><name><surname>Vuillemard</surname><given-names>JC</given-names></name></person-group><article-title>Biochemical characteristics of fermented milk produced by mixed cultures of lactic starters and bifidobacteria</article-title><source>Lait</source><volume>80</volume><fpage>465</fpage><lpage>478</lpage><year>2000</year><pub-id pub-id-type="doi">10.1051/lait:2000138</pub-id></element-citation></ref>
<ref id="b6-br-0-0-1150"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharp</surname><given-names>R</given-names></name><name><surname>Fishbain</surname><given-names>S</given-names></name><name><surname>Macfarlane</surname><given-names>GT</given-names></name></person-group><article-title>Effect of short-chain carbohydrates on human intestinal bifidobacteria and Escherichia coli in vitro</article-title><source>J Med Microbiol</source><volume>50</volume><fpage>152</fpage><lpage>160</lpage><year>2001</year><pub-id pub-id-type="doi">10.1099/0022-1317-50-2-152</pub-id><pub-id pub-id-type="pmid">11211222</pub-id></element-citation></ref>
<ref id="b7-br-0-0-1150"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Gu</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>YQ</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name></person-group><article-title>In vitro fermentation of fructooligosaccharides with human gut bacteria</article-title><source>Food Funct</source><volume>6</volume><fpage>947</fpage><lpage>954</lpage><year>2015</year><pub-id pub-id-type="doi">10.1039/C4FO01082E</pub-id><pub-id pub-id-type="pmid">25653214</pub-id></element-citation></ref>
<ref id="b8-br-0-0-1150"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cummings</surname><given-names>JH</given-names></name><name><surname>Macfarlane</surname><given-names>GT</given-names></name><name><surname>Englyst</surname><given-names>HN</given-names></name></person-group><article-title>Prebiotic digestion and fermentation</article-title><source>Am J Clin Nutr</source><volume>73</volume><fpage>415S</fpage><lpage>420S</lpage><year>2001</year><pub-id pub-id-type="doi">10.1093/ajcn/73.2.415s</pub-id><pub-id pub-id-type="pmid">11157351</pub-id></element-citation></ref>
<ref id="b9-br-0-0-1150"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>KR</given-names></name><name><surname>Naik</surname><given-names>SR</given-names></name><name><surname>Vakil</surname><given-names>BV</given-names></name></person-group><article-title>Probiotics, prebiotics and synbiotics- a review</article-title><source>J Food Sci Technol</source><volume>52</volume><fpage>7577</fpage><lpage>7587</lpage><year>2015</year><pub-id pub-id-type="doi">10.1007/s13197-015-1921-1</pub-id><pub-id pub-id-type="pmid">26604335</pub-id></element-citation></ref>
<ref id="b10-br-0-0-1150"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fekjaer</surname><given-names>HO</given-names></name></person-group><article-title>Alcohol - a universal preventive agent? A critical analysis</article-title><source>Addiction</source><volume>108</volume><fpage>2051</fpage><lpage>2057</lpage><year>2013</year><pub-id pub-id-type="doi">10.1111/add.12104</pub-id><pub-id pub-id-type="pmid">23297738</pub-id></element-citation></ref>
<ref id="b11-br-0-0-1150"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mu&#x00F1;oz</surname><given-names>G</given-names></name><name><surname>Urrutia</surname><given-names>JC</given-names></name><name><surname>Burgos</surname><given-names>CF</given-names></name><name><surname>Silva</surname><given-names>V</given-names></name><name><surname>Aguilar</surname><given-names>F</given-names></name><name><surname>Sama</surname><given-names>M</given-names></name><name><surname>Yeh</surname><given-names>HH</given-names></name><name><surname>Opazo</surname><given-names>C</given-names></name><name><surname>Aguayo</surname><given-names>LG</given-names></name></person-group><article-title>Low concentrations of ethanol protect against synaptotoxicity induced by A&#x03B2; in hippocampal neurons</article-title><source>Neurobiol Aging</source><volume>36</volume><fpage>845</fpage><lpage>856</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2014.10.017</pub-id><pub-id pub-id-type="pmid">25433458</pub-id></element-citation></ref>
<ref id="b12-br-0-0-1150"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>MK</given-names></name><name><surname>Ronveaux</surname><given-names>CC</given-names></name><name><surname>Rust</surname><given-names>BM</given-names></name><name><surname>Newman</surname><given-names>JW</given-names></name><name><surname>Hawley</surname><given-names>M</given-names></name><name><surname>Barile</surname><given-names>D</given-names></name><name><surname>Mills</surname><given-names>DA</given-names></name><name><surname>Raybould</surname><given-names>HE</given-names></name></person-group><article-title>Prebiotic milk oligosaccharides prevent development of obese phenotype, impairment of gut permeability, and microbial dysbiosis in high fat-fed mice</article-title><source>Am J Physiol Gastrointest Liver Physiol</source><volume>312</volume><fpage>G474</fpage><lpage>G487</lpage><year>2017</year><pub-id pub-id-type="doi">10.1152/ajpgi.00427.2016</pub-id><pub-id pub-id-type="pmid">28280143</pub-id></element-citation></ref>
<ref id="b13-br-0-0-1150"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tunapong</surname><given-names>W</given-names></name><name><surname>Apaijai</surname><given-names>N</given-names></name><name><surname>Yasom</surname><given-names>S</given-names></name><name><surname>Tanajak</surname><given-names>P</given-names></name><name><surname>Wanchai</surname><given-names>K</given-names></name><name><surname>Chunchai</surname><given-names>T</given-names></name><name><surname>Kerdphoo</surname><given-names>S</given-names></name><name><surname>Eaimworawuthikul</surname><given-names>S</given-names></name><name><surname>Thiennimitr</surname><given-names>P</given-names></name><name><surname>Pongchaidecha</surname><given-names>A</given-names></name><etal/></person-group><article-title>Chronic treatment with prebiotics, probiotics and synbiotics attenuated cardiac dysfunction by improving cardiac mitochondrial dysfunction in male obese insulin resistant rats</article-title><source>Eur J Nutr</source><volume>57</volume><fpage>2091</fpage><lpage>2104</lpage><year>2018</year><pub-id pub-id-type="doi">10.1007/s00394-017-1482-3</pub-id><pub-id pub-id-type="pmid">28608320</pub-id></element-citation></ref>
<ref id="b14-br-0-0-1150"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Iwamoto</surname><given-names>A</given-names></name><name><surname>Kumrungsee</surname><given-names>T</given-names></name><name><surname>Okazaki</surname><given-names>Y</given-names></name><name><surname>Kuroda</surname><given-names>M</given-names></name><name><surname>Yamaguchi</surname><given-names>S</given-names></name><name><surname>Kato</surname><given-names>N</given-names></name></person-group><article-title>Consumption of an acid protease derived from Aspergillus oryzae causes bifidogenic effect in rats</article-title><source>Nutr Res</source><volume>44</volume><fpage>60</fpage><lpage>66</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.nutres.2017.06.004</pub-id><pub-id pub-id-type="pmid">28821318</pub-id></element-citation></ref>
<ref id="b15-br-0-0-1150"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coudray</surname><given-names>C</given-names></name><name><surname>Tressol</surname><given-names>JC</given-names></name><name><surname>Gueux</surname><given-names>E</given-names></name><name><surname>Rayssiguier</surname><given-names>Y</given-names></name></person-group><article-title>Effects of inulin-type fructans of different chain length and type of branching on intestinal absorption and balance of calcium and magnesium in rats</article-title><source>Eur J Nutr</source><volume>42</volume><fpage>91</fpage><lpage>98</lpage><year>2003</year><pub-id pub-id-type="doi">10.1007/s00394-003-0390-x</pub-id><pub-id pub-id-type="pmid">12638030</pub-id></element-citation></ref>
<ref id="b16-br-0-0-1150"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reeves</surname><given-names>PG</given-names></name><name><surname>Nielsen</surname><given-names>FH</given-names></name><name><surname>Fahey</surname><given-names>GC</given-names><suffix>Jr</suffix></name></person-group><article-title>AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet</article-title><source>J Nutr</source><volume>123</volume><fpage>1939</fpage><lpage>1951</lpage><year>1993</year><pub-id pub-id-type="doi">10.1093/jn/123.11.1939</pub-id><pub-id pub-id-type="pmid">8229312</pub-id></element-citation></ref>
<ref id="b17-br-0-0-1150"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heit</surname><given-names>C</given-names></name><name><surname>Eriksson</surname><given-names>P</given-names></name><name><surname>Thompson</surname><given-names>DC</given-names></name><name><surname>Charkoftaki</surname><given-names>G</given-names></name><name><surname>Fritz</surname><given-names>KS</given-names></name><name><surname>Vasiliou</surname><given-names>V</given-names></name></person-group><article-title>Quantification of Neural Ethanol and Acetaldehyde Using Headspace GC-MS</article-title><source>Alcohol Clin Exp Res</source><volume>40</volume><fpage>1825</fpage><lpage>1831</lpage><year>2016</year><pub-id pub-id-type="doi">10.1111/acer.13156</pub-id><pub-id pub-id-type="pmid">27501276</pub-id></element-citation></ref>
<ref id="b18-br-0-0-1150"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okazaki</surname><given-names>Y</given-names></name><name><surname>Tomotake</surname><given-names>H</given-names></name><name><surname>Tsujimoto</surname><given-names>K</given-names></name><name><surname>Sasaki</surname><given-names>M</given-names></name><name><surname>Kato</surname><given-names>N</given-names></name></person-group><article-title>Consumption of a resistant protein, sericin, elevates fecal immunoglobulin A, mucins, and cecal organic acids in rats fed a high-fat diet</article-title><source>J Nutr</source><volume>141</volume><fpage>1975</fpage><lpage>1981</lpage><year>2011</year><pub-id pub-id-type="doi">10.3945/jn.111.144246</pub-id><pub-id pub-id-type="pmid">21940508</pub-id></element-citation></ref>
<ref id="b19-br-0-0-1150"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nosova</surname><given-names>T</given-names></name><name><surname>Jousimies-Somer</surname><given-names>H</given-names></name><name><surname>Jokelainen</surname><given-names>K</given-names></name><name><surname>Heine</surname><given-names>R</given-names></name><name><surname>Salaspuro</surname><given-names>M</given-names></name></person-group><article-title>Acetaldehyde production and metabolism by human indigenous and probiotic Lactobacillus and Bifidobacterium strains</article-title><source>Alcohol Alcohol</source><volume>35</volume><fpage>561</fpage><lpage>568</lpage><year>2000</year><pub-id pub-id-type="doi">10.1093/alcalc/35.6.561</pub-id><pub-id pub-id-type="pmid">11093962</pub-id></element-citation></ref>
<ref id="b20-br-0-0-1150"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Kandasamy</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Kirby</surname><given-names>CW</given-names></name><name><surname>Karakach</surname><given-names>T</given-names></name><name><surname>Hafting</surname><given-names>J</given-names></name><name><surname>Critchley</surname><given-names>AT</given-names></name><name><surname>Evans</surname><given-names>F</given-names></name><name><surname>Prithiviraj</surname><given-names>B</given-names></name><name><surname>Prithiviraj</surname><given-names>B</given-names></name></person-group><article-title>Prebiotic effects of diet supplemented with the cultivated red seaweed Chondrus crispus or with fructo-oligo-saccharide on host immunity, colonic microbiota and gut microbial metabolites</article-title><source>BMC Complement Altern Med</source><volume>15</volume><fpage>279</fpage><year>2015</year><pub-id pub-id-type="doi">10.1186/s12906-015-0802-5</pub-id><pub-id pub-id-type="pmid">26271359</pub-id></element-citation></ref>
<ref id="b21-br-0-0-1150"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rehm</surname><given-names>J</given-names></name><name><surname>Gmel</surname><given-names>GE</given-names><suffix>Sr</suffix></name><name><surname>Gmel</surname><given-names>G</given-names></name><name><surname>Hasan</surname><given-names>OSM</given-names></name><name><surname>Imtiaz</surname><given-names>S</given-names></name><name><surname>Popova</surname><given-names>S</given-names></name><name><surname>Probst</surname><given-names>C</given-names></name><name><surname>Roerecke</surname><given-names>M</given-names></name><name><surname>Room</surname><given-names>R</given-names></name><name><surname>Samokhvalov</surname><given-names>AV</given-names></name><etal/></person-group><article-title>The relationship between different dimensions of alcohol use and the burden of disease-an update</article-title><source>Addiction</source><volume>112</volume><fpage>968</fpage><lpage>1001</lpage><year>2017</year><pub-id pub-id-type="doi">10.1111/add.13757</pub-id><pub-id pub-id-type="pmid">28220587</pub-id></element-citation></ref>
<ref id="b22-br-0-0-1150"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osaki</surname><given-names>A</given-names></name><name><surname>Okazaki</surname><given-names>Y</given-names></name><name><surname>Kimoto</surname><given-names>A</given-names></name><name><surname>Izu</surname><given-names>H</given-names></name><name><surname>Kato</surname><given-names>N</given-names></name></person-group><article-title>Beneficial effect of a low dose of ethanol on liver function and serum urate in rats fed a high-fat diet</article-title><source>J Nutr Sci Vitaminol (Tokyo)</source><volume>60</volume><fpage>408</fpage><lpage>412</lpage><year>2014</year><pub-id pub-id-type="doi">10.3177/jnsv.60.408</pub-id><pub-id pub-id-type="pmid">25866304</pub-id></element-citation></ref>
<ref id="b23-br-0-0-1150"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimoto</surname><given-names>A</given-names></name><name><surname>Izu</surname><given-names>H</given-names></name><name><surname>Fu</surname><given-names>C</given-names></name><name><surname>Suidasari</surname><given-names>S</given-names></name><name><surname>Kato</surname><given-names>N</given-names></name></person-group><article-title>Effects of low dose of ethanol on the senescence score, brain function and gene expression in senescence-accelerated mice 8 (SAMP8)</article-title><source>Exp Ther Med</source><volume>14</volume><fpage>1433</fpage><lpage>1440</lpage><year>2017</year><pub-id pub-id-type="doi">10.3892/etm.2017.4633</pub-id><pub-id pub-id-type="pmid">28810607</pub-id></element-citation></ref>
<ref id="b24-br-0-0-1150"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name></person-group><article-title>Modulation of Intestinal Barrier and Bacterial Endotoxin Production Contributes to the Beneficial Effect of Nicotinic Acid on Alcohol-Induced Endotoxemia and Hepatic Inflammation in Rats</article-title><source>Biomolecules</source><volume>5</volume><fpage>2643</fpage><lpage>2658</lpage><year>2015</year><pub-id pub-id-type="doi">10.3390/biom5042643</pub-id><pub-id pub-id-type="pmid">26501337</pub-id></element-citation></ref>
<ref id="b25-br-0-0-1150"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chopyk</surname><given-names>DM</given-names></name><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Raeman</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Smith</surname><given-names>T</given-names></name><name><surname>Anania</surname><given-names>FA</given-names></name></person-group><article-title>Dysregulation of junctional adhesion molecule-A contributes to ethanol-induced barrier disruption in intestinal epithelial cell monolayers</article-title><source>Physiol Rep</source><volume>5</volume><fpage>e13541</fpage><year>2017</year><pub-id pub-id-type="doi">10.14814/phy2.13541</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-br-0-0-1150" position="float">
<label>Figure 1.</label>
<caption><p>Effect of dietary FOS on ethanol levels in the ileum and cecum digesta of rats. (A) &#x0395;thanol levels per gram of ileum digesta; (B) ethanol levels in total ileum digesta; (C) ethanol levels per gram of cecum digesta; (D) ethanol levels in total cecum digesta. Values represent the means &#x00B1; standard error of the mean (n=8). &#x002A;P&#x003C;0.01 vs. control group by Student&#x0027;s t-test. FOS, fructooligosaccharides.</p></caption>
<graphic xlink:href="br-09-05-0427-g00.jpg"/>
</fig>
<fig id="f2-br-0-0-1150" position="float">
<label>Figure 2.</label>
<caption><p>Association of ethanol levels with number of <italic>Bifidobacterium</italic> spp. per gram of cecum digesta.</p></caption>
<graphic xlink:href="br-09-05-0427-g01.jpg"/>
</fig>
<fig id="f3-br-0-0-1150" position="float">
<label>Figure 3.</label>
<caption><p>Association of ethanol levels with the levels of (A) acetate, (B) lactate, (C) propionate and (D) n-butyrate per gram of cecum digesta.</p></caption>
<graphic xlink:href="br-09-05-0427-g02.jpg"/>
</fig>
<table-wrap id="tI-br-0-0-1150" position="float">
<label>Table I.</label>
<caption><p>Composition of the experimental diets.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="bottom" colspan="2">Proportion of diet (&#x0025;)</th>
</tr>
<tr>
<th/>
<th align="center" valign="bottom" colspan="2"><hr/></th>
</tr>
<tr>
<th align="left" valign="bottom">Material</th>
<th align="center" valign="bottom">Control</th>
<th align="center" valign="bottom">10&#x0025; FOS</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Beef tallow<sup><xref rid="tfn2-br-0-0-1150" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">30.0</td>
<td align="center" valign="top">30.0</td>
</tr>
<tr>
<td align="left" valign="top">Casein<sup><xref rid="tfn3-br-0-0-1150" ref-type="table-fn">b</xref></sup></td>
<td align="center" valign="top">20.0</td>
<td align="center" valign="top">20.0</td>
</tr>
<tr>
<td align="left" valign="top">L-Cystine<sup><xref rid="tfn2-br-0-0-1150" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">0.3</td>
<td align="center" valign="top">0.3</td>
</tr>
<tr>
<td align="left" valign="top">Vitamin mixture<sup><xref rid="tfn4-br-0-0-1150" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">1.0</td>
<td align="center" valign="top">1.0</td>
</tr>
<tr>
<td align="left" valign="top">Mineral mixture<sup><xref rid="tfn4-br-0-0-1150" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">3.5</td>
<td align="center" valign="top">3.5</td>
</tr>
<tr>
<td align="left" valign="top">Cellulose<sup><xref rid="tfn4-br-0-0-1150" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">5.0</td>
<td align="center" valign="top">5.0</td>
</tr>
<tr>
<td align="left" valign="top">Sucrose<sup><xref rid="tfn2-br-0-0-1150" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="top">20.0</td>
<td align="center" valign="top">20.0</td>
</tr>
<tr>
<td align="left" valign="top">Corn starch<sup><xref rid="tfn4-br-0-0-1150" ref-type="table-fn">c</xref></sup></td>
<td align="center" valign="top">20.2</td>
<td align="center" valign="top">10.2</td>
</tr>
<tr>
<td align="left" valign="top">FOS<sup><xref rid="tfn5-br-0-0-1150" ref-type="table-fn">d</xref></sup></td>
<td align="center" valign="top">&#x2212;</td>
<td align="center" valign="top">10.0</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1-br-0-0-1150"><p>10&#x0025; FOS Dietary components were from</p></fn>
<fn id="tfn2-br-0-0-1150"><label>a</label><p>Nacalai Tesque Inc., Kyoto, Japan</p></fn>
<fn id="tfn3-br-0-0-1150"><label>b</label><p>Sigma-Aldrich; Merck KGaA, Darmstadt, Germany</p></fn>
<fn id="tfn4-br-0-0-1150"><label>c</label><p>Hiroshima Laboratory Animal Centre, Hiroshima, Japan</p></fn>
<fn id="tfn5-br-0-0-1150"><label>d</label><p>Wako Pure Chemical Industries, Ltd., Osaka, Japan. The vitamin and mineral mixtures were used according to the American Institute for Nutrition formulation (AIN-93) (<xref rid="b16-br-0-0-1150" ref-type="bibr">16</xref>). FOS, fructooligosaccharides.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tII-br-0-0-1150" position="float">
<label>Table II.</label>
<caption><p>Effects of dietary FOS on the copy numbers of beneficial bacteria and levels of SCFAs in the cecum digesta of rats.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th/>
<th align="center" valign="bottom" colspan="2">Dietary group</th>
</tr>
<tr>
<th/>
<th align="center" valign="bottom" colspan="2"><hr/></th>
</tr>
<tr>
<th align="left" valign="bottom">Variable</th>
<th align="center" valign="bottom">Control</th>
<th align="center" valign="bottom">10&#x0025; FOS</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Final body weight, g</td>
<td align="center" valign="top">198.1&#x00B1;1.9</td>
<td align="center" valign="top">193.9&#x00B1;3.2</td>
</tr>
<tr>
<td align="left" valign="top">Total food intake over 14 days, g</td>
<td align="center" valign="top">225.0&#x00B1;0.0</td>
<td align="center" valign="top">225.0&#x00B1;0.0</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3">Bacteria (numbers/g digesta)</td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;<italic>Bifidobacterium</italic> spp. (&#x00D7;10<sup>8</sup>)</td>
<td align="center" valign="top">1.4&#x00B1;0.5</td>
<td align="center" valign="top">5.9&#x00B1;1.8<sup><xref rid="tfn7-br-0-0-1150" ref-type="table-fn">a</xref>&#x002A;</sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;<italic>Lactobacillus</italic> spp. (&#x00D7;10<sup>9</sup>)</td>
<td align="center" valign="top">11.5&#x00B1;3.1</td>
<td align="center" valign="top">7.5&#x00B1;4.7</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3">Bacteria (numbers/total digesta)</td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;<italic>Bifidobacterium</italic> spp. (&#x00D7;10<sup>8</sup>)</td>
<td align="center" valign="top">1.3&#x00B1;0.3</td>
<td align="center" valign="top">31.6&#x00B1;9.6<sup><xref rid="tfn7-br-0-0-1150" ref-type="table-fn">a</xref>&#x002A;</sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;<italic>Lactobacillus</italic> spp. (&#x00D7;10<sup>10</sup>)</td>
<td align="center" valign="top">1.5&#x00B1;0.3</td>
<td align="center" valign="top">3.5&#x00B1;2.3</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3">SCFAs (&#x00B5;mol/g digesta)</td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Succinate</td>
<td align="center" valign="top">36.2&#x00B1;7.3&#x002A;</td>
<td align="center" valign="top">14.8&#x00B1;5.5<sup><xref rid="tfn7-br-0-0-1150" ref-type="table-fn">a</xref>&#x002A;&#x002A;</sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Lactate</td>
<td align="center" valign="top">15.2&#x00B1;4.7&#x002A;</td>
<td align="center" valign="top">35.8&#x00B1;4.6<sup><xref rid="tfn8-br-0-0-1150" ref-type="table-fn">b</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Acetate</td>
<td align="center" valign="top">66.3&#x00B1;6.9</td>
<td align="center" valign="top">24.4&#x00B1;6.2<sup><xref rid="tfn8-br-0-0-1150" ref-type="table-fn">b</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Propionate</td>
<td align="center" valign="top">20.1&#x00B1;1.7</td>
<td align="center" valign="top">33.7&#x00B1;4.9<sup><xref rid="tfn7-br-0-0-1150" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;n-Butyrate</td>
<td align="center" valign="top">15.5&#x00B1;1.8</td>
<td align="center" valign="top">22.3&#x00B1;2.1<sup><xref rid="tfn7-br-0-0-1150" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Total SCFAs</td>
<td align="center" valign="top">127.2&#x00B1;16.9&#x002A;&#x002A;</td>
<td align="center" valign="top">123.0&#x00B1;13.5&#x002A;&#x002A;</td>
</tr>
<tr>
<td align="left" valign="top" colspan="3">SCFAs (&#x00B5;mol/total digesta)</td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Succinate</td>
<td align="center" valign="top">49.0&#x00B1;11.2&#x002A;</td>
<td align="center" valign="top">73.1&#x00B1;23.9&#x002A;&#x002A;</td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Lactate</td>
<td align="center" valign="top">19.3&#x00B1;4.7&#x002A;</td>
<td align="center" valign="top">195.2&#x00B1;29.4<sup><xref rid="tfn8-br-0-0-1150" ref-type="table-fn">b</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Acetate</td>
<td align="center" valign="top">86.0&#x00B1;7.5</td>
<td align="center" valign="top">119.7&#x00B1;23.7</td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Propionate</td>
<td align="center" valign="top">26.3&#x00B1;1.9</td>
<td align="center" valign="top">189.7&#x00B1;34.6<sup><xref rid="tfn8-br-0-0-1150" ref-type="table-fn">b</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;n-Butyrate</td>
<td align="center" valign="top">20.3&#x00B1;2.1</td>
<td align="center" valign="top">119.7&#x00B1;11.5<sup><xref rid="tfn8-br-0-0-1150" ref-type="table-fn">b</xref></sup></td>
</tr>
<tr>
<td align="left" valign="top">&#x00A0;&#x00A0;Total SCFAs</td>
<td align="center" valign="top">164.7&#x00B1;19.4&#x002A;&#x002A;</td>
<td align="center" valign="top">656.2&#x00B1;66.5<sup><xref rid="tfn8-br-0-0-1150" ref-type="table-fn">b</xref>&#x002A;&#x002A;</sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn6-br-0-0-1150"><p>Values represent the means &#x00B1; standard error of the mean (n=6-8). &#x002A; and &#x002A;&#x002A; indicate studies using 6 and 7 animals, respectively, and others are the data of 8 animals; outlier data were omitted from certain studies following confirmation with the Smirnov-Grubbs rejection test.</p></fn>
<fn id="tfn7-br-0-0-1150"><label>a</label><p>P&#x003C;0.05</p></fn>
<fn id="tfn8-br-0-0-1150"><label>b</label><p>P&#x003C;0.01 vs. control determined by Student&#x0027;s t-test. FOS, fructooligosaccharides; SCFAs, short-chain fatty acids.</p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
